Oncology
Symposium
Stop immune tolerance in lung cancer!
Translational
Aims : To update oncologists, pulmonologists, and thoracic surgeons regarding the new lung cancer treatment options as well as immunologists, pathologists, and researchers on the immune mechanisms in lung cancer, new research directions, and the methods that are used in practice to evaluate the anti-cancer responses and immune status of cancer patients.
14:45
How to define the immune status of lung cancer patient
J. Domagała-Kulawik(Warszawa, Poland)
COI
1
4446
15:15
Reversing the suppression of T-cells: the role of monoclonal antibodies
J. Aerts(Rotterdam, Netherlands)
COI
2
4447
15:45
A novel approach to anti-cancer vaccines
T. Wehler(Homburg (Saar), Germany)
COI
3
4448
16:15
Chemotherapy triggered crosstalk between tumor and immune cells
Y. Ma(Paris, France)
COI
4
4449
. . .
